Future investigation is required to determine whether A-/T + or A+/T- individuals defined by plasma Aβ42/Aβ40 and plasma p-Tau181 have evidence of Aβ plaques, tau tangles, brain atrophy, and cognitive decline. The gene discussed is MAPT; the disease is Brain atrophy.